Search results
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Finance Canada· 1 week agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Zacks via Yahoo Finance Canada· 2 weeks agoFollowing the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to...
Bolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoWorkforce Reduction: Approximately 50% reduction announced. Cash Runway Extension: Expected to extend into the second half of 2026. Leadership Changes: Transition of CEO from Randy Schatzman ...
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 2 months agoOmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript May 10, 2024 OmniAb, Inc. isn’t one of...
Q1 2024 BioNTech SE Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 2 months agoParticipants Jens H. Holstein; CFO & Member of Management Board; BioNTech SE Ozlem Tureci; Co-Founder, Chief Medical Officer & Member of Management Board; BioNTech SE Ryan Richardson; Chief ...
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoExplore key insights from Comstock Inc's Q1 2024 earnings, including significant revenue streams, strategic investments, and future financial strategies.
UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via Yahoo Finance Canada· 2 months agoThe U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said ...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance Canada· 2 months agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
Denmark's Genmab to acquire ProfoundBio for $1.8 billion
Reuters via Yahoo Finance Canada· 3 months agoThe acquisition will give Genmab worldwide rights to three candidates in clinical development, they said. Genmab shares were down 1.7% at 0955 GMT. Jyske bank analyst Henrik Hallengreen Laustsen ...
Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK
Zacks via Yahoo Finance Canada· 4 months agoThis week, the FDA granted priority review status to supplemental biologics license applications...
